Company Search:
Advanced Search
Sponsored Links
Merck KGaA Company Snapshot
Merck KGaA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Merck KGaA with three other pharmaceutical manufacturers in Europe: Novo Nordisk As of DENMARK (2020 sales of 126.95 billion Danish Kroner [US$19.79 billion] of which 85% was Diabetes and obesity), UCB Sa of BELGIUM (5.35 billion Euros [US$6.20 billion] of which 34% was Cimzia), and AstraZeneca PLC which is based in UNITED KINGDOM (£20.59 billion [US$28.37 billion] of which 41% was Oncology).

Sales Analysis. During the second quarter of 2021, sales at Merck KGaA totalled 4.87 billion Euro. This is an increase of 18.2% from the 4.12 billion Euro in sales at the company during the second quarter of 2020. This was the largest same quarter increase in sales since the third quarter of 2016. During the first two quarters of 2021, sales totalled 9.50 billion Euro, which is 11.9% higher than through the first two quarters of 2020. During the previous 12 quarters, sales at Merck KGaA have increased compared with the same quarter in the previous year. Merck KGaA reported sales of 17.53 billion Euro (US$20.34 billion) for the year ending December of 2020. This represents an increase of 8.6% versus 2019, when the company's sales were 16.15 billion Euro. Sales of Electronics saw an increase that was more than double the company's growth rate: sales were up 31.3% in 2020, from 2.57 billion Euro to 3.38 billion Euro. Not all segments of Merck KGaA experienced an increase in sales in 2020: sales of Healthcare fell 1.1% to 6.64 billion Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Merck KGaA
  Stock Performance Chart for Merck KGaA
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 202.40
(Figures in Euros )
1 Week 5.2%   13 Weeks 3.9%  
4 Weeks 16.4%   52 Weeks 53.5%  
Merck KGaA Key Data:
  Ticker: MRK Country: Germany
  Exchanges: FRA GVA OTH ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 17,534,000,000
(Year Ending Jan 2021).
Employees: 58,096
  Currency: Euros Market Cap: 87,999,042,507
  Fiscal Yr Ends: December Shares Outstanding: 434,777,878
  Share Type: Stammaktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.